Management of the urban crisis : government and the behavioral sciences. /

Por Seashore, Stanley E., McNeill, Robert J.
Publicado em 1971.

BRAF Mutations Open Doors for N-Ethyl-N-Nitrosourea–Induced Gliomagenesis

Por McNeill, Robert S., Irvin, David M., Miller, C. Ryan
Publicado no Am J Pathol (2016)

Contemporary murine models in preclinical astrocytoma drug development

Por McNeill, Robert S., Vitucci, Mark, Wu, Jing, Miller, C. Ryan
Publicado no Neuro Oncol (2015)

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial

Por Frederich, Robert, McNeill, Robert, Berglind, Niklas, Fleming, Douglas, Chen, Roland
Publicado em 2012

Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models

Por Irvin, David M., McNeill, Robert S., Bash, Ryan E., Miller, C. Ryan
Publicado no Brain Pathol (2016)

CSIG-14 DE-DIFFERENTIATION OF ASTROCYTES INTO GLIOBLASTOMA STEM CELLS THROUGH CORE PATHWAY MUTATIONS

Por Schmid, Ralf, Vitucci, Mark, McNeill, Robert, Bash, Ryan, Werneke, Andrea, Huey, Lauren, White, Kristen, Ewend, Matthew, Wu, Jing, Miller, C. Ryan
Publicado no Neuro Oncol (2015)

Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process

Por Galvao, Rui Pedro, Kasina, Anita, McNeill, Robert S., Harbin, Jordan E., Foreman, Oded, Verhaak, Roel G. W., Nishiyama, Akiko, Miller, C. Ryan, Zong, Hui
Publicado em 2014

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Por McNeill, Robert S., Schmid, Ralf S., Bash, Ryan E., Vitucci, Mark, White, Kristen K., Werneke, Andrea M., Constance, Brian H., Huff, Byron, Miller, C. Ryan
Publicado no J Vis Exp (2014)

ATPS-55 INFLUENCE OF MAPK AND PI3K PATHWAY MUTATIONS ON RESPONSE TO TARGETED INHIBITORS

Por McNeill, Robert S., Canoutas, Demitra A., Schmid, Ralf S., Bash, Ryan E., Constance, Brian H., Azam, Salma H., Reuther, Rachel A., Johnson, Gary L., Miller, C. Ryan
Publicado no Neuro Oncol (2015)

Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis

Por Vitucci, Mark, Karpinich, Natalie O., Bash, Ryan E., Werneke, Andrea M., Schmid, Ralf S., White, Kristen K., McNeill, Robert S., Huff, Byron, Wang, Sophie, Van Dyke, Terry, Miller, C. Ryan
Publicado em 2013

Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide

Por Schmid, Ralf S., Simon, Jeremy M., Vitucci, Mark, McNeill, Robert S., Bash, Ryan E., Werneke, Andrea M., Huey, Lauren, White, Kristen K., Ewend, Matthew G., Wu, Jing, Miller, C. Ryan
Publicado no Neuro Oncol (2016)

Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma

Por Vitucci, Mark, Irvin, David M, McNeill, Robert S, Schmid, Ralf S, Simon, Jeremy M, Dhruv, Harshil D, Siegel, Marni B, Werneke, Andrea M, Bash, Ryan E, Kim, Seungchan, Berens, Michael E, Miller, C Ryan
Publicado no Neuro Oncol (2017)

PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition

Por McNeill, Robert S., Stroobant, Emily E., Smithberger, Erin, Canoutas, Demitra A., Butler, Madison K., Shelton, Abigail K., Patel, Shrey D., Limas, Juanita C., Skinner, Kasey R., Bash, Ryan E., Schmid, Ralf S., Miller, C. Ryan
Publicado no PLoS One (2018)

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer

Por Van Swearingen, Amanda E D, Sambade, Maria J, Siegel, Marni B, Sud, Shivani, McNeill, Robert S, Bevill, Samantha M, Chen, Xin, Bash, Ryan E, Mounsey, Louisa, Golitz, Brian T, Santos, Charlene, Deal, Allison, Parker, Joel S, Rashid, Naim, Miller, C Ryan, Johnson, Gary L, Anders, Carey K
Publicado no Neuro Oncol (2017)

Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma

Por McNeill, Robert S, Canoutas, Demitra A, Stuhlmiller, Timothy J, Dhruv, Harshil D, Irvin, David M, Bash, Ryan E, Angus, Steven P, Herring, Laura E, Simon, Jeremy M, Skinner, Kasey R, Limas, Juanita C, Chen, Xin, Schmid, Ralf S, Siegel, Marni B, Van Swearingen, Amanda E D, Hadler, Michael J, Sulman, Erik P, Sarkaria, Jann N, Anders, Carey K, Graves, Lee M, Berens, Michael E, Johnson, Gary L, Miller, C Ryan
Publicado no Neuro Oncol (2017)